|Articles|August 1, 2008
August Global News
Industry news tidbits from around the world.
Advertisement
- Quanticate, a UK-based CRO announced its expansion into the United States via new offices in Cambridge, MA. Earlier this year, the company announced its formation as the merger of two CROs: Statwood and Oxford Pharmaceutical Sciences. It has over 200 employees on three continents.
- Synergy Research Group (Moscow) and Metrics Research (Karachi, Pakistan) have established a CRO alliance. The Metrics' alliance extends Synergy's ability to offer global trial capabilities to sponsors. It already has alliances in Europe, India, the United States, and the Ukraine.
- Lombardia, Italy, is the recipient of a multiyear project to establish a Center of Excellence for Clinical Research. The Lombardia Ministry of Health chose the expertise of the Clinical Research Consortium of Massachusetts (CRCM), which was tapped by the Massachusetts Office of International Trade and Investment (MOITI). Consortium members include BBK Worldwide, Court Square Group, Phase Forward, and Tufts Medical Center's Institute for Clinical Research & Health Policy Studies. CRCM members and MOITI are also pitching the Centers of Excellence for Clinical Research plan to three Latin American countries and two others in Europe.
- European Pharmaceutical Industry Association's (Brussels, Belgium) new Code of Practice went into effect, requiring each company to make publicly available a list of patient organizations to which it provides direct or indirect financial support, or significant nonfinancial support.
Articles in this issue
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Operational Strategies That Strengthened the NIMBLE Trial DesignSeptember 16th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
2
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
3
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
4
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
